Skip to main content

Table 4 Biological tolerance to the two ACTs on days 0 and 7

From: A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire

  Day Artemisinine/naphtoquine Artemather/lumefantrine
Aneamia 0 29/60 23/60
(Hb < 11 g/d)   48.3% 38.3%
  7 36/60 34
   60% 56.7%
Craetinemia > 14 0 0/60 1/60
   0% 1.7%
  7 0/60 1/60
   0% 1.7%
SGOT > 48 0 0/60 0/60
   0% 0%
  7 0/60 0/60
   0% 0%
SGPT > 45 0 0/60 1/60
   0% 1.7%
  7 0/60 1/60
   0% 1.7%